ERCC6 and Ataxia: The next-generation sequencing panel targeted for ataxia genes evidenced ERCC6 variants, in the absence of other systemic signs suggestive of CS, as shown by the low diagnostic scores (clinical 0/20; clinical–radiological 3/39) and high severity score (14/15).